Friday 13 December 2019
Home      All news      Contact us      Chinese
straitstimes - 23 days ago

Singapore medical company invents non-invasive cancer screening receives US$20m in funding

November 20, 2019 2:28 PM

SINGAPORE - Local genomic medicine company Lucence announced on Wednesday (Nov 20) that it has received US$20 million (S$27.23 million) in initial funding after it invented a non-invasive test for late-stage cancer detection.


Latest News
Hashtags:   

Singapore

 | 

medical

 | 

company

 | 

invents

 | 

invasive

 | 

cancer

 | 

screening

 | 

receives

 | 

funding

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources